Cardiovascular risk in women with nonspecific chest pain

Women's Health

Volumn 4, Issue 6, 2008, Pages 561-564

  Woodward, Mark ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Chest pain; Coronary artery disease; Hormone therapy

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; PLACEBO; SEX HORMONE; VITAMIN D;

ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE MARKER; DRUG SAFETY; FAMILY HISTORY; FATALITY; FEMALE; HEART FAILURE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYSTERECTOMY; INTERNATIONAL CLASSIFICATION OF DISEASES; LOW FAT DIET; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTMENOPAUSE; RISK ASSESSMENT; RISK REDUCTION; THORAX PAIN;

EID: 59349103741     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.6.561     Document Type: Article

References (14)

1. Robinson JG, Wallace R, Limacher M et al.: Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative hormone trials). Am. J. Cardiol. 102(6), 693-699 (2008).
2. Boie ET: Initial evaluation of chest pain. Emerg. Med. Clin. North Am. 23, 937-957 (2005).
3. Bugiardini R: Women, 'non-specific' chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome. Eur. Heart J. 27, 1387-1389 (2006).
4. Klinkman MS, Stevens D, Gorenflo DW: Episodes of care for chest pain: a preliminary report from MIRNET. J. Fam. Pract. 38, 345-352 (1994).
5. Bugiardini R, Bairey Merz CN: Angina with 'normal' coronary arteries. A changing philosophy. JAMA 293, 477-484 (2005).
6. Johnson BD, Shaw LJ, Pepine CJ et al.: Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur. Heart J. 27, 1408-1415 (2006).
7. Eslick GD: Classification, natural history, epidemiology, and risk factors of noncardiac chest pain. Dis. Mon. 54, 593-603 (2008).
8. Prentice RL, Anderson GL: The women's health initiative: lessons learned. Annu. Rev. Public Health 29. 131-150 (2008).
9. Anderson GL, Limacher M, Assaf AR et al.: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712 (2004).
10. Rossouw JE, Anderson GL, Prentice RL et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333 (2002).
11. Woodward M: Epidemiology: Study Design and Data Analysis (Second Edition). Chapman and Hall/CRC Press, Boca Raton, FL, USA (2005).
12. Robinson JG, Wallace R, Limacher M et al.: Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk. J. Womens Health (Larchmt) 15, 1151-1160 (2006).
13. International Classification of Diseases: Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death (Ninth Revision). Geneva, Switzerland, World Health Organization (1977).
14. Hulley S, Grady D, Bush T et al.: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) research group. JAMA 280, 605-613 (1998).